Document ID: chunk:federal_register_of_legislation:F2024C01281:clause:1ab_531
Version: federal_register_of_legislation:F2024C01281
Segment Type: clause
Provision Reference: sch 1AB cl 531
Character Range: 1317519–1318892

531       mRNA vaccines and treatments                                                                                                                         To develop and maintain Australia's onshore capability to manufacture mRNA vaccines and products, including by purchasing mRNA vaccines and products manufactured onshore, as a measure to give effect to Australia's obligations under the International Covenant on Economic, Social and Cultural Rights, particularly Articles 2 and 12.
                                                                                                                                                               This objective also has the effect it would have if it were limited to measures:
                                                                                                                                                               (a) for the provision of, or incidental to the provision of, pharmaceutical, sickness or hospital benefits or medical services (within the meaning of paragraph 51(xxiiiA) of the Constitution); or
                                                                                                                                                               (b) that are peculiarly adapted to the government of a nation and cannot otherwise be carried on for the benefit of the nation.